QIAGEN N.V. (QGEN) is a biological products, (no diagnostic substances) company incorporated in Netherlands, listed on the NYSE. With a market capitalization of $10.1 billion, QIAGEN N.V. is a large-cap company. The stock currently trades at $48.83, down 1.95% today, with a 52-week range of $37.63–$57.82. The company trades at a trailing P/E of 23.9x and a forward P/E of 17.5x. QIAGEN N.V. pays an annual dividend yield of 0.53%.
No 10-K filings found.